Filing search / Terns Pharmaceuticals, Inc. / "Benefits" / Page 4

8-K

EX-99.1

voh3xlf1

14 Jun 21

Terns Reports Positive Top-line Results from Phase 2a LIFT Study of FXR Agonist TERN-101 in Patients with NASH

4:40pm

10-Q

sth02 10ne3swpvl23xw

14 May 21

Quarterly report

4:59pm

8-K

EX-99.1

ra1yo8wjjhlx

13 May 21

Terns Reports First Quarter 2021 Financial Results and Provides Corporate Update

4:17pm

10-K

bb6bcydilhj51

30 Mar 21

Annual report

5:21pm

10-K

EX-4.3

wbe nntu5

30 Mar 21

Annual report

5:21pm

8-K

EX-99.1

qd7 bp0z94j9mueycy

30 Mar 21

Terns Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

5:04pm

S-8

EX-99.2

qy31t

12 Feb 21

Registration of securities for employees

5:06pm

424B4

zlz0pgfzk7lm 7053zz

8 Feb 21

Prospectus supplement with pricing info

4:01pm

S-1/A

EX-10.5

e4yr6i

1 Feb 21

IPO registration (amended)

7:05am

S-1/A

EX-10.7

b315irxjxthbit68w2gf

1 Feb 21

IPO registration (amended)

7:05am

S-1/A

EX-10.11

0f8ijw3 pg7hf

1 Feb 21

IPO registration (amended)

7:05am

S-1/A

EX-10.5

xye8awtdr5g

1 Feb 21

IPO registration (amended)

7:05am

S-1/A

EX-10.9

57pgh7jvjjk

1 Feb 21

IPO registration (amended)

7:05am

S-1/A

EX-10.5

imdxqe

1 Feb 21

IPO registration (amended)

7:05am

S-1/A

jmb ycxr9zp5e

1 Feb 21

IPO registration (amended)

7:05am

S-1/A

EX-1.1

k13x6a4e2f1o

1 Feb 21

IPO registration (amended)

7:05am

S-1/A

EX-10.5

x7qlh06fx2gsgaj

1 Feb 21

IPO registration (amended)

7:05am

S-1/A

EX-10.8

6hj4wdr

1 Feb 21

IPO registration (amended)

7:05am

S-1

cq0pxw9uu4uf

15 Jan 21

IPO registration

5:22pm